Researchers from North Carolina State University have synthesized an analog of lipoxazolidinone A, a small molecule that is effective against drug-resistant bacteria such as MRSA. This molecule, a new synthetic compound inspired by a natural product, could be a useful chemical tool for studying other Gram-positive infections and may have implications for future drug creation.
Lipoxazolidinone A is a natural product which had been previously isolated from bacteria living in marine sediments. It is a secondary metabolite – a small molecule produced by the bacteria that isn’t key to its survival but is produced for a secondary purpose, like defense. When lipoxazolidinone A was initially isolated, researchers noted that it seemed effective against Gram-positive bacteria, like MRSA.
NC State chemist Joshua Pierce aimed to confirm those original findings and understand how the molecule’s structure correlated to its function; in short, he wanted to recreate the molecule to see what portions were directly responsible for its anti-microbial properties and then potentially improve upon that structure.
Pierce, along with current NC State graduate student Kaylib Robinson and former students Jonathan Mills and Troy Zehnder, used novel chemical tools to synthesize lipoxazolidinone A in the lab. They were able to confirm that its chemical structure matched what the initial researchers had indicated, then they worked to identify the portion of the molecule that was responsible for the activity against Gram-positive bacteria. Their result was a compound with improved potency, JJM-35.
They tested JJM-35 against a panel of resistant and non-resistant bacteria. When tested against MRSA in vitro, they found that the synthesized molecule was up to 50 times more effective than the natural product against several bacterial strains. Additionally, they found that the molecule was often more effective against resistant bacterial strains than it was against nonresistant strains.
“An exciting additional aspect of this work was that we identified that these molecules may function by inhibiting multiple biosynthetic pathways directly or indirectly,” says Pierce. “This means that bacteria may have difficulty developing resistance to potential drugs developed from these molecules.”
While more work is needed, Pierce hopes that JJM-35 and similar compounds can be used as tools to study other Gram-positive bacteria and provide a platform for the development of a novel class of anti-infective agents.
“At this point, we have a chemical scaffold – a starting piece of the puzzle. We know that this piece is effective, and so right now all efforts are focused on evaluating the properties of these molecules and their in vivo efficacy,” says Pierce. “The hope is that we can build upon this scaffold to create drugs that are effective against MRSA and other resistant bacteria at a time of dire need for antimicrobial development while also increasing the spectrum of activity.”
The Latest on: Antimicrobial development
via Google News
The Latest on: Antimicrobial development
Global Infection prevention & Control Market Analysis & Forecast 2014-2020, With an Expected CAGR of 5.3% - ResearchAndMarkets.com
on June 13, 2018 at 3:21 am
DUBLIN--(BUSINESS WIRE)--The "Infection prevention & Control Market: By Infections; By Antimicrobial Drugs ... prevention and control is the major and significant step in the development and maintenance of products in the Medical Devices, Pharmaceuticals ... […]
Talis Biomedical Corporation awarded $5.6M by NIH
on June 12, 2018 at 8:41 am
The indiscriminate use and misuse of antibiotics has led to an impending global health crisis: the development of widespread antibiotic resistance. Bloodstream infections (BSI) are particularly significant with respect to their clinical impact: severe ... […]
Global Antimicrobial Ingredients Market Growth, Application and Price by Analysis 2017 - 2026
on June 11, 2018 at 9:14 am
The study has observed the evolution of new and hybrid substances exhibiting high antimicrobial properties. Outcomes of recent scientific undertakings towards development of new antimicrobial ingredients have been studied. Moreover, factors influencing the ... […]
Common antimicrobial in toothpaste & other products
on June 10, 2018 at 10:03 am
The antimicrobial chemical triclosan is in thousands of products ... including aggravating inflammation in the gut and promoting the development colon cancer by altering the gut microbiota, the community of microbes found in our intestines. […]
PLOS ONE celebrates the launch of the Antimicrobial Resistance Channel
on June 7, 2018 at 5:48 am
In recognition of the importance of this threat and the potential research can play, PLOS has collaborated with the Global Antibiotic Research & Development Partnership (GARDP) to launch a new PLOS Channel devoted to Antimicrobial resistance. Overseen by 8 ... […]
Antimicrobial Susceptibility Test Market to Reach US $3,814.0 Mn by 2025
on May 18, 2018 at 10:11 am
Based on application, the global antimicrobial susceptibility test market has been divided into clinical diagnosis, drug discovery & development, and others. In terms of end-user, the global market has been classified into diagnostic laboratories ... […]
Antimicrobial Suture Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2022
on April 25, 2018 at 9:55 am
Antimicrobial Suture Market analysis is provided for United States market including development trends by regions, competitive analysis of Antimicrobial Suture market. This report studies the Antimicrobial Suture market, Suture is a specific linear suture ... […]
via Bing News